BMY Competitors & Alternatives
Compare Bristol-Myers Squibb Company with similar stocks in the same industry
Drug Manufacturers - General
BMY
Main Stock$65.31
Tradestie Score
51
Market Cap
$96.54B
P/E Ratio
18.2
Revenue Growth
0.0%
Analyst Upside
-3.6%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVS
Novartis AG
|
$156.15
|
$254.99B | 24.0 | 56 | Compare |
|
ABT
Abbott Laboratories
|
$105.70
|
$232.30B | 35.0 | 52 | Compare |
|
MRK
Merck & Co., Inc.
|
$130.20
|
$225.13B | 36.8 | 56 | Compare |
|
AMGN
Amgen Inc
|
$385.16
|
$160.70B | 27.0 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$25.01
|
$154.70B | 19.0 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$130.21
|
$137.92B | 18.1 | 54 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.08
|
$121.27B | 19.9 | 46 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$51.69
|
$91.59B | 17.0 | 49 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$202.95
|
$22.61B | 36.9 | 55 | Compare |
|
GRFS
Grifois, S.A.
|
$7.87
|
$6.78B | 10.8 | 53 | Compare |
More BMY Analysis
Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry